Status:

UNKNOWN

Motive-specific Intervention for Negative Symptoms in Schizophrenia

Lead Sponsor:

University of Zurich

Conditions:

Negative Type; Schizophrenic

Anhedonia

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The aim of this study is to test a therapeutic intervention to reduce negative symptomatic among schizophrenia patients. Since the intervention can take place within an inpatient stay, it is a short i...

Detailed Description

Clinically relevant negative symptoms are present in almost 60% of all patients suffering from schizophrenia. Motivational deficits seem to be one of the main barriers in the process of "functional re...

Eligibility Criteria

Inclusion

  • Informed Consent as documented by signature
  • Male and female inpatients between 18 and 65 years of age
  • ICD-10 diagnosis of psychosis (F2)
  • Clinical relevant negative symptoms
  • Ability to judge with regard to decisions on study participation
  • Fluent in German and able to understand the instructions

Exclusion

  • Florid positive psychotic symptoms (measured with PANSS; that is any positive-subscale item score higher than five)
  • Post-schizophrenic depression (ICD: F20.4)
  • Organic schizophrenia-like disorder (ICD: F0.6)
  • Known or suspected non-compliance, drug or alcohol abuse during treatment
  • Cognitive impairments: strongly below average values in cognitive tests
  • Complete stop or restart of taking antipsychotic medication during the study (dose adjustments are not a reason for exclusion)
  • Previous enrolment in the current study
  • Enrolment of the investigator, his/her family members, employees and other dependent persons.

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2022

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT04793438

Start Date

January 1 2021

End Date

June 30 2022

Last Update

March 11 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Psychiatric University Hospital

Zurich, Canton of Zurich, Switzerland, 8032